Vaccines and photodynamic therapies for oral microbial-related diseases

Current Drug Metabolism

Volumn 10, Issue 1, 2009, Pages 90-94

  Liu, Pei Feng ^a,b   Zhu, Wen Hong ^c   Huang, Chun Ming ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antimicrobial agent treatment; Photodynamic therapy; Traditional peridontal surgery; Vaccine therapy

Indexed keywords

ABC TRANSPORTER; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL VACCINE; BETA LACTAMASE; CETYLPYRIDINIUM SALT; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; ENOLASE; IMMUNOGLOBULIN A; METRONIDAZOLE; POLYGLACTIN; PROSTAGLANDIN E2; TETRACYCLINE; ANTIINFECTIVE AGENT; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIGEN ANTIBODY REACTION; CENTRAL NERVOUS SYSTEM DISEASE; DENTAL CARIES; DIARRHEA; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EPIGASTRIC BURNING; GINGIVA DISEASE; GINGIVITIS; HALITOSIS; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; LIVER DYSFUNCTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH INFECTION; NAUSEA; NONHUMAN; ORAL SURGERY; PERIODONTAL DISEASE; PERIODONTAL SURGERY; PERIODONTITIS; PERIPHERAL NEUROPATHY; PHOTODYNAMIC THERAPY; REVIEW; STREPTOCOCCUS INFECTION; TOOTH PLAQUE; VACCINE PRODUCTION; VOMITING; ANIMAL; BACTERIAL INFECTION; METHODOLOGY; MICROBIOLOGY; MOUTH DISEASE; PHOTOCHEMOTHERAPY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DENTAL CARIES; DRUG RESISTANCE, BACTERIAL; HALITOSIS; HUMANS; MOUTH DISEASES; PERIODONTAL DISEASES; PHOTOCHEMOTHERAPY; VACCINES;

EID: 62749196222     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009787048365     Document Type: Review

References (64)

1. Marcotte, H.; Lavoie, M.C. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol. Mol. Biol. Rev., 1998, 62(1), 71-109.
2. Smith D. J.; Anderson, J. M.; King, W. F.; van Houte, J.; Taubman, M. A. Oral streptococcal colonization of infants. Oral Microbiol. Immunol., 1993, 8, 1-4.
3. Marsh, P.; Martin, M. Oral Microbiology, 3rd ed.; Chapman & Hall: London, 1992.
4. Nolte, W.A. Oral Microbiology: With Basic Microbiology and Immunology, 4th ed.;The C.V. Mosby Co: St. Louis, 1982.
5. Theilade, E. Human Microbial Ecology; Hill, M.J.; Marsh, P.D. Ed.; CRC Press:Boca Raton, 1990; pp. 1-56.
6. Bowden, G.H.; Hardie, J.M.; Slack, G.L. Microbial variations in approximal dental plaque. Caries Res., 1975, 9, 253-277.
7. Slots, J. Microflora in the healthy gingival sulcus in man. Scand. J. Dent. Res., 1977, 85, 247-254.
8. Li, X.J.; Kolltveit, K.M.; Tronstad, L.; Olsen, I. Systemic diseases caused by oral infection. Clin. Micro. Rev., 2000, 13(4), 547-558.
9. Loesche, W.J. Role of Streptococcus mutans in human dental decay. Microbiol. Rev., 1986, 50, 353-380.
10. Nyvad, B. Microbial colonization of human tooth surfaces. Acta Pathol. Microbiol. Immunol. Scand., 1993, 101, 7-45.
11. Slots, J.; Rams, T.E. Microbiology of Periodontal Disease; Slots J.; Taubman M.A.,Ed.; Mosby-Year Book: St. Louis, 1992; pp. 425-443.
12. Marsh, P.D. Sugar, fluoride, pH and microbial homeostasis in dental plaque. Proc. Finn. Dent. Soc., 1991, 87, 515-525.
13. Marsh, P.D. Microbial ecology of dental plaque and its significance in health and disease. Adv. Dent. Res., 1994, 8, 263-271.
14. Genco, R.J. Host responses in periodontal diseases: current concepts. J. Periodontol., 1992, 63, 338-355.
15. Genco, R.J.; Slots, J. Host responses in periodontal diseases. J. Dent. Res., 1984, 63, 441-451.
16. Garcia, R.I; Henshaw, M.M.; Krall, E.A. Relationship between periodontal disease and systemic health. Periodontology, 2000, 25 (1), 21-36.
17. Persson, S.; Claesson, R.; Carlsson, J. The capacity of subgingival microbiotasto produce volatile sulfur compounds in human serum. Oral Microbiol. Immunol.,1989, 4, 169-172.
18. Persson, S.; Edlund, M.B.; Claesson, R.; Carlsson, J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol. Immunol., 1990, 5, 195-201.
19. Kleinberg, I.; Westbay, G. Oral malodor. Crit. Rev. Oral. Biol. Med., 1999, 1, 247-259.
20. Tonzetich, J. Production and origin of oral malodor: a review of mechanisms andmethods of analysis. J. Periodontol., 1977, 48, 13-20.
21. Könönen, E.; Asikainen, S.; Jousimies-Somer, H. The early colonization ofgram-negative anaerobic bacteria in edentulous infants. Oral. Microbiol. Immunol.,1992, 7, 28-31.
22. Könönen, E.; Asikainen, S.; Saarela, M., Karjalainen, J.; Jousimies-Somer,H. The oral gram-negative anaerobic microflora in young children: longitudinalchanges from edentulous to dentate mouth. Oral Microbiol. Immunol., 1994, 9, 136-141.
23. Cleland, W.P. Opportunities and obstacles in veterinary dental drug delivery. Adv. Drug. Deliv. Rev., 2001, 50(3), 261-275.
24. Aurer, A.; PlanEak, D. Antimicrobial treatment of periodontal diseases. Acta Stomat. Croat., 2004, 38, 67-72.
25. Feres, M.; Haffajee, A.D.; Allard, K.; Som, S.; Goodson, J.M.; Socransk, S.S. Antibiotic resistance of subgingival species during and after antibiotic therapy. J. Clin. Periodontol., 2002, 29, 724-735.
26. Kastner, U.; Guggenbichler, J.P. Influence of macrolide antibiotics on promotionof resistance in the oral flora of children. Infection, 2001, 29, 251-256.
27. Villedieu, A.; Diaz-Torres, M.L.; Hunt, N.; McNab, R.; Spratt, D.A.; Wilson, M.;Mullany, P. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob. Agents Chemother., 2003, 47(3), 878-882.
28. Dejonge, H.R. Toxicity of tetracyclines in rat-small-intestinal epithelium and liver. Biochem. Pharmacol., 1973, 22, 2659-2677.
29. Berndt, W.O. Renal toxicology. In Handbook of Toxicology; Haley T.J.; BemdtW.O., Ed.; Hemisphere: Washington, 1987; pp.185.
30. Dletz, D.D.; Abdo, K.M.; Haseman, J.K.; Eustis, S.L.; Huff, J.E. Comparativetoxicity and carcinogenicity studies of tetracycline and xytoetracycline in rats and mice. Fundam. Appl. Toxicol., 1991, 17, 335-346.
31. Mitchell, D.A. Metronidazole: Its use in clinical dentistry. J. Clin. Periodontol.,1984, 11(3), 145-158.
32. Roe, F.J.C. Metronidazole: view of uses and toxicity. J. Antimicrob. Chemother.,1977, 3, 205-212.
33. Horlen, C.K.; Seifert, C.F.; Malouf, C.S. Toxic metronidazole-induced MRI changes. Ann. Pharmacother., 2000, 34, 1273-1275.
34. Al-Haroni, M.; Skaug, N.; Bakken, V.; Cash, P. Proteomic analysis ofampicillin-resistant oral Fusobacterium nucleatum. Oral Microbiol. Immunol., 2008, 23(1), 36-42.
35. Grenier, D.; Bertrand, J.; Mayrand, D. Porphyromonas gingivalis outer membranevesicles promote bacterial resistance to chlorhexidine. Oral Microbiol. Immunol.,1995, 10, 319-320.
36. Lin, G.H.; Voss, K.A.; Davidson, T.J. Acute inhalation toxicity of cetylpyridiniumchloride. Food Chem. Toxicol., 1991, 29(12), 851-854.
37. Hajishengallis, G.; Michalek, S. M. Current status of a mucosal vaccine against dental caries. Oral Microbiol. Immunol., 1999, 14, 1-20.
38. Michalek, S.M.; Katz, J.; Childers, N.K. A vaccine against dental caries: an overview. BioDrugs, 2001, 15 (8), 501-508.
39. Russell, M.W.; Childers, N.K.; Michalek, S.M.; Smith, D.J.; Taubman, M.A. A caries vaccine? Caries Res., 2004, 38 (3), 230-235.
40. Han, T.K.; Dao, M.L. Differential immunogenicity of a DNA vaccine containing the Streptococcus mutans wall-associated protein A gene versus that containing a truncated derivative antigen A lacking in the hydrophobic carboxyterminal region. DNA Cell Biol., 2005, 24 (9), 574-581.
41. Childers, N.K.; Li, F.; Dasanayake, A.P.; Li, Y.; Kirk, K.; Michalek, S.M. Immuneresponse in humans to a nasal boost with Streptococcus mutans antigens. Oral Microbiol. Immunol., 2006, 21, 309-313.
42. Wallengren, M.L.L.; Hamberg, K.; Ericson, D.; Nordberg, J. Low salivary IgAactivity to cell-surface antigens of mutans streptococci related to HLA-DRB1*04. Oral. Microbiol. Immunol., 2005, 20(2), 73-81.
43. Wallengren, M.L.; Hamberg, K.; Ericson, D. Salivary IgA reactions to cell-surfaceantigens of oral streptococci. Oral Microbiol. Immunol., 2004, 19(3),188-195.
44. Zhao, H.; Wu, B.; Wu, H.; Su, L.Y.; Pang, J.L.; Yang, T.H.; Liu, Y.L. Protectiveimmunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co-glycolicacid) microspheres. Biotechnol. Lett., 2006, 28, 1299-1304.
45. Johnson, N.W.; Curtis, M.A. Preventive therapy for periodontal diseases. Adv. Dent. Res., 1994, 8 (2), 337-348.
46. Persson, G.R. Immune responses and vaccination against periodontal infections. J. Clin. Periodontol., 2005, 2 (Suppl. 6), 39-53.
47. Roberts, F.A.; Houston, L.S.; Lukehart, S.A.; Mancl, L.A.; Persson, G.R.; Page,R.C. Periodontitis vaccine decreases local prostaglandin E2 levels in a primate model.Infec. Immun., 2004, 72 (2), 1166-1168.
48. Nilsson, C.L. Bacterial proteomics and vaccine development. Am. J. Pharmacogenomics, 2002, 2 (1), 59-65.
49. Shah, H.N.; Keys, C.J.; Schmid, O.; Gharbia, S.E. Clin. Matrix-assisted laserdesorption/ionization time-of-flight mass spectrometry and proteomics: a new era inanaerobic microbiology. Infect. Dis., 2002, 35 (Suppl. 1), S58-64.
50. Pervaiz, S.H.; Olivo, M. Art and science of photodynamic therapy. Clin. Exp. Pharmacol. Physiol., 2006, 33, 551-556.
51. Hamblin, M.R.; Hasan, T. Photodynamic therapy: a new antimicrobial approachto infectious disease? Photochem. Photobiol. Sci., 2004, 3, 436-450.
52. Jori, G. Photodynamic therapy of microbial infections: state of the art and perspectives. J. Environ. Pathol. Toxicol. Oncol. Pathol. Toxicol. Oncol., 2006, 25 (1-2), 505-519.
53. Soukos, N.S.; Chen, P.S.Y.; Morris, J.T.; Ruggiero, K.; Abernethy, A.D.; Som, S.;Foschi, F.; Doucette, S.; Bammann, L.L.; Fontana, C.R.; Doukas, A.G.; Stashenko,P.P. Photodynamic therapy for endodontic disinfection. J. Endod., 2006, 32 (10),979-984.
54. Konopka, K.; Goslinski, T. Photodynamic therapy in dentistry. J. Dent. Res., 2007, 86 (8), 694-707.
55. Rovaldi, C. R.; Pievsky, A.; Sole, N. A.; Friden, P. M.; Rothstein, D. M.;Spacciapoli, P. Photoactive porphyrin derivative with broad-spectrum activityagainst oral pathogens in vitro. Antimicrob. Agents and Chemother., 2000, 44(12), 3364-3367.
56. Sigusch, B.W.; Pfitzner, A.; Albrecht, V.; Glockmann, E. Efficacy of photodynamic therapy on inflammatory signs and two selected perodontopathogenic species in a beagle dog model. J. Periodontol., 2005, 76,1100-1105.
57. Fonseca, M.B.; Tessare Junior, P.O.; Pallota, R.C.; Filho, H.F.; Porto Denardin,O.V.; Rapoport, A.; Dedivitis, R.A.; Veronezi, J.F.; Genovese, W.J.; Franco Ricardo,A.L. Photodynamic therapy for root canals infected with Enterococcus faecalis. Photomed. Laser Surg., 2008, 26(3), 209-213.
58. Wilson, M. Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections. Photochem. Photobiol. Sci., 2004, 3, 412-418.
59. Dobson, J.; Wilson, M. Sensitisation of oral bacteria in biofilms to killing by light from a low-power laser. Arch. Oral. Biol., 1992, 37(11), 883-887.
60. O'Neil, J.F., Hope, C.K.; Wilson, M. Oral bacteria in multi-species biofilms can bekilled by red light in the presence of toluidine blue. Lasers Surg. Med., 2002, 31,86-90.
61. Bevilacqua, I.M.; Nicolau, R.A.; Khouri, S., Brugnera Jr. A.; Teodoro, G.R.;Zangaro, R.A.; Pacheco, M.T.T. The impact of photodynamic therapy on the viability of Streptococcus mutans in a planktonic culture. Photomed. Laser Surg., 2007, 25(6), 513-518.
62. Pfitzner, A.; Sigusch, B.W.; Albrecht, V.; Glockmann, E. Killing of periodontopathogenic bacteria by photodynamic therapy. J. Periodontol., 2004, 75, 1343-1349.
63. Colombo, A.V.; Silva, C.M.; Haffajee, A.; Vieira A.P. Identification of oral bacteria associated with crevicular epithelial cells from chronic periodontitis lesions. J. Med. Microbiol., 2006, 55, 609-615.
64. Macarthur, D.J.; Jacques, N.A. Proteome analysis of oral pathogens. J. Dent. Res., 2003, 82 (11), 870-876.